Bringing ayurvedic treatment to mainstream

Over the past 3 months, Kapiva Ayurveda has got in strategic investors, diluting almost 10% of the business into equity

Shrey Badhani (left) and Ameve Sharma, co-founders of Kapiva Ayurveda
Premium

Shrey Badhani (left) and Ameve Sharma, co-founders of Kapiva Ayurveda

Romita Majumdar
Ayurvedic medicines still continue to be viewed as only a niche alternative to mainstream allopathic drugs. Baidyanath scion Ameve Sharma and entrepreneur Shrey Badhani set out to change this perception in 2015 via Kapiva Ayurveda, with a range of wellness products with both FDA (the US drug regulator) and GMP (Good Manufacturing Practice) certification.

“The products stemmed from a need to introduce allopathy-like doses of ayurvedic remedies for the millennial consumer. While both of us grew up on a steady dose of Ayurveda, we felt friends and colleagues in our age group did not trust the products, as they were not uniformly certified,” said Sharma.

Over the past three months, Kapiva Ayurveda has got in strategic investors, diluting almost 10 per cent

First Published: Nov 19 2017 | 11:14 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com